These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38349159)

  • 1. Effect of the aggregated protein dye YAT2150 on
    Román-Álamo L; Avalos-Padilla Y; Bouzón-Arnáiz I; Iglesias V; Fernández-Lajo J; Monteiro JM; Rivas L; Fisa R; Riera C; Andreu D; Pintado-Grima C; Ventura S; Arce EM; Muñoz-Torrero D; Fernàndez-Busquets X
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0112723. PubMed ID: 38349159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising aryl selenoate derivatives as antileishmanial agents and their effects on gene expression.
    Fernández-Rubio C; Rubio-Hernández M; Alcolea V; Burguete-Mikeo A; Nguewa PA; Pérez-Silanes S
    Antimicrob Agents Chemother; 2024 Apr; 68(4):e0155923. PubMed ID: 38497616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis.
    Freitas CS; Santiago SS; Lage DP; Antinarelli LMR; Oliveira FM; Vale DL; Martins VT; Magalhaes LND; Bandeira RS; Ramos FF; Pereira IAG; de Jesus MM; Ludolf F; Tavares GSV; Costa AV; Ferreira RS; Coimbra ES; Teixeira RR; Coelho EAF
    Exp Parasitol; 2023 Aug; 251():108555. PubMed ID: 37247802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Antileishmanial Potential of C-3 Functionalized Isobenzofuranones against Leishmania (Leishmania) Infantum Chagasi.
    Pereira WL; de Souza Vasconcellos R; Mariotini-Moura C; Saar Gomes R; Firmino Rde C; da Silva AM; Silva Júnior A; Bressan GC; Almeida MR; Crocco Afonso LC; Teixeira RR; Lopes Rangel Fietto J
    Molecules; 2015 Dec; 20(12):22435-44. PubMed ID: 26694330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protein aggregation inhibitor YAT2150 has potent antimalarial activity in Plasmodium falciparum in vitro cultures.
    Bouzón-Arnáiz I; Avalos-Padilla Y; Biosca A; Caño-Prades O; Román-Álamo L; Valle J; Andreu D; Moita D; Prudêncio M; Arce EM; Muñoz-Torrero D; Fernàndez-Busquets X
    BMC Biol; 2022 Oct; 20(1):197. PubMed ID: 36271358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
    Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum.
    Lage PS; Chávez-Fumagalli MA; Mesquita JT; Mata LM; Fernandes SO; Cardoso VN; Soto M; Tavares CA; Leite JP; Tempone AG; Coelho EA
    Parasitol Res; 2015 Dec; 114(12):4625-35. PubMed ID: 26346453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species.
    Mendonça DVC; Lage DP; Calixto SL; Ottoni FM; Tavares GSV; Ludolf F; Chávez-Fumagalli MA; Schneider MS; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Parasitol Res; 2018 Feb; 117(2):391-403. PubMed ID: 29248978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antileishmanial effects of Physalis angulata root extract on Leishmania infantum.
    Da Silva BJM; Pereira SWG; Rodrigues APD; Do Nascimento JLM; Silva EO
    J Integr Med; 2018 Nov; 16(6):404-410. PubMed ID: 30195443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
    Reis TAR; Oliveira-da-Silva JA; Tavares GSV; Mendonça DVC; Freitas CS; Costa RR; Lage DP; Martins VT; Machado AS; Ramos FF; Silva AM; Ludolf F; Antinarelli LMR; Brito RCF; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Coimbra ES; Coelho EAF
    Exp Parasitol; 2021 Feb; 221():108059. PubMed ID: 33338468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents.
    Sereno D; Lemesre JL
    Antimicrob Agents Chemother; 1997 May; 41(5):972-6. PubMed ID: 9145854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine.
    Villa-Pulgarín JA; Gajate C; Botet J; Jimenez A; Justies N; Varela-M RE; Cuesta-Marbán Á; Müller I; Modolell M; Revuelta JL; Mollinedo F
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005805. PubMed ID: 28829771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine H1-receptor antagonists against Leishmania (L.) infantum: an in vitro and in vivo evaluation using phosphatidylserine-liposomes.
    Pinto EG; da Costa-Silva TA; Tempone AG
    Acta Trop; 2014 Sep; 137():206-10. PubMed ID: 24905294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro drug susceptibility using a parasite-rescue and transformation assay of Leishmania (Mundinia) martiniquensis and Leishmania (Mundinia) orientalis amastigotes against antileishmanial drugs.
    Kimcharoensuk S; Leelayoova S; Mungthin M; Nawattanapaibool N; Tan-Ariya P; Siripattanapipong S
    Acta Trop; 2024 Jan; 249():107081. PubMed ID: 37993039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antileishmanial activity of leaf and stem extracts of seven Brazilian plant species.
    de Paula RC; da Silva SM; Faria KF; Frézard F; Moreira CPS; Foubert K; Lopes JCD; Campana PRV; Rocha MP; Silva AF; Silva CG; Pieters L; Almeida VL
    J Ethnopharmacol; 2019 Mar; 232():155-164. PubMed ID: 30580025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol analogues present effective antileishmanial activity against promastigotes and amastigotes from distinct Leishmania species by multitarget action in the parasites.
    Antinarelli LMR; Meinel RS; Coelho EAF; da Silva AD; Coimbra ES
    J Pharm Pharmacol; 2019 Dec; 71(12):1854-1863. PubMed ID: 31595530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pamidronate, a promising repositioning drug to treat leishmaniasis, displays antileishmanial and immunomodulatory potential.
    Ribeiro JM; Rodrigues-Alves ML; Oliveira E; Guimarães PPG; Maria Murta Santi A; Teixeira-Carvalho A; Murta SMF; Peruhype-Magalhães V; Souza-Fagundes EM
    Int Immunopharmacol; 2022 Sep; 110():108952. PubMed ID: 35716482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.